Tracing the evolution and progression of bladder cancer from epigenetic origins to clinical early diagnostics

Authors

Institutions

Publication Details

Journal
Oncology and Translational Medicine
Published
2026-04-01
DOI
https://doi.org/10.1097/ot9.0000000000000135
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tracing the evolution and progression of bladder cancer from epigenetic origins to clinical early diagnostics

Shenjuan Li, Fangjin Chen, Lingao Ju, Zilin Xu et al.
Oncology and Translational Medicine
Bladder and Urothelial Cancer Treatments
article

Tracing the evolution and progression of bladder cancer from epigenetic origins to clinical early diagnostics

Shenjuan Li, Fangjin Chen, Lingao Ju, Zilin Xu, Min Yu, Yao Xiao, Wan Xiang, Gang Wang, Kaiyu Qian
article en

Abstract

No abstract available for this paper.
Oncology and Translational Medicine
Peking University (CN), Wuhan University (CN), Wuhan Business University (CN), Zhongnan Hospital of Wuhan University (CN), Center for Life Sciences (CN)
Good health and well-being
Openalex Percentile: Top 31%
Bladder and Urothelial Cancer Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tracing the evolution and progression of bladder cancer from epigenetic origins to clinical early diagnostics — Shenjuan Li, Fangjin Chen, et al. · Oncology and Translational Medicine (2026) | TGRS Research Map | TGRS